Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores

Transfusion Medicine

Volumn 16, Issue 2, 2006, Pages 93-100

  Niemann, C U ^a   Behrends, M ^a,b   Quan, D ^c   Eilers, H ^a   Gropper, M A ^a   Roberts, J P ^a   Hirose, R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Liver transplantation; MELD; Recombinant factor VIIa; Transfusion

Indexed keywords

ALBUMIN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYSTALLOID; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; LIVER TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; COMPARATIVE STUDY; ERYTHROCYTE TRANSFUSION; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE;

ADULT; ERYTHROCYTE TRANSFUSION; FACTOR VII; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 33745007623     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2006.00653.x     Document Type: Article

References (26)

1. Amitrano L. Guardascione M.A. Brancaccio V. Balzano A. ( 2002) Coagulation disorders in liver disease. Seminars in Liver Disease, 22, 83 96.
2. Bernstein D.E. Jeffers L. Erhardtsen E. Reddy K.R. Glazer S. Squiban P. Bech R. Hedner U. Schiff E.R. ( 1997) Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology, 113, 1930 1937.
3. Boks A.L. Brommer E.J. Schalm S.W. Van Vliet H.H. ( 1986) Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage. Hepatology, 6, 79 86.
4. Dalmau A. Sabate A. Acosta F. Garcia-Huete L. Koo M. Sansano T. Rafecas A. Figueras J. Jaurrieta E. Parrilla P. ( 2000) Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesthesia and Analgesia, 91, 29 34.
5. Ejlersen E. Melsen T. Ingerslev J. Andreasen R.B. Vilstrup H. ( 2001) Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scandinavian Journal of Gastroenterology, 36, 1081 1085.
6. Ghorashian S. Hunt B.J. ( 2004) 'Off-license' use of recombinant activated factor VII. Blood Reviews, 18, 245 259.
7. He S. Blomback M. Jacobsson Ekman G. Hedner U. ( 2003) The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. Journal of Thrombosis and Haemostasis, 1, 1215 1219.
8. Hedner U. ( 2000) Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000. Seminars in Thrombosis and Haemostasis, 26, 363 366.
9. Hedner U. Erhardtsen E. ( 2002) Potential role for rFVIIa in transfusion medicine. Transfusion, 42, 114 124.
10. Hendriks H.G. Meijer K. De Wolf J.T. Klompmaker I.J. Porte R.J. De Kam P.J. Hagenaars A.J. Melsen T. Slooff M.J. Van Der Meer J. ( 2001) Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation, 71, 402 405.
11. Hoffman R. Mahajana A. Agmon P. Baruch Y. Brenner B. ( 2002) Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy. Thrombosis and Haemostasis, 87, 346 347.
12. Jeffers L. Chalasani N. Balart L. Pyrsopoulos N. Erhardtsen E. ( 2002) Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology, 123, 118 126.
13. Kalicinski P. Kaminski A. Drewniak T. Ismail H. Szymczak M. Markiewicz M. Lukasiewicz H. ( 1999) Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII. Transplantation proceedings, 31, 378 379.
14. Kositchaiwat C. Chuansumrit A. ( 2001) Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP). Thrombosis and Haemostasis, 86, 1125 1126.
15. Lechner K. Niessner H. Thaler E. ( 1977) Coagulation abnormalities in liver disease. Seminars in Thrombosis and Haemostasis, 4, 40 56.
16. Lodge J.P. Jonas S. Oussoultzoglou E. Malago M. Jayr C. Cherqui D. Anthuber M. Mirza D.F. Kuhlman L. Bechstein W.O. Diaz J.C. Tartiere J. Eyraud D. Fridberg M. Erhardtsen E. Mimoz O. ( 2005) Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology, 102, 269 275.
17. Markiewicz M. Kalicinski P. Kaminski A. Laniewski P. Ismail H. Drewniak T. Szymczak M. Nachulewicz P. ( 2003) Acute coagulopathy after reperfusion of the liver graft in children correction with recombinant activated factor VII. Transplantation Proceedings, 35, 2318 2319.
18. Mor E. Jennings L. Gonwa T.A. Holman M.J. Gibbs J. Solomon H. Goldstein R.M. Husberg B.S. Watemberg I.A. Klintmalm G.B. ( 1993) The impact of operative bleeding on outcome in transplantation of the liver. Surgery Gynecology & Obstetrics, 176, 219 227.
19. Niemann C.U. Hirose R. Stock P. Roberts J.P. Mandell S. Spencer Yost C. ( 2004) Intraoperative fluid management of living donor versus cadaveric liver transplant recipients. Transplantation Proceedings, 36, 1466 1468.
20. Nonthasoot B. Nivatvongs S. ( 2003) Multiple doses of recombinant factor VIIa in orthotopic liver transplantation: a case report. Transplantation Proceedings, 35, 427 428.
21. Pereira S.P. Langley P.G. Williams R. ( 1996) The management of abnormalities of hemostasis in acute liver failure. Seminars in Liver Disease, 16, 403 414.
22. Planinsic R.M. Van Der Meer J. Testa G. Grande L. Candela A. Porte R.J. Ghobrial R.M. Isoniemi H. Schelde P.B. Erhardtsen E. Klintmalm G. Emre S. ( 2005) Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transplantation, 11, 895 900.
23. Porte R.J. Molenaar I.Q. Begliomini B. Groenland T.H. Januszkiewicz A. Lindgren L. Palareti G. Hermans J. Terpstra O.T. ( 2000) Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet, 355, 1303 1309.
24. Rao L.V. Rapaport S.I. ( 1990) Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa. Blood, 75, 1069 1073.
25. Surudo T. Wojcicki M. Milkiewicz P. Czuprynska M. Lubikowski J. Jarosz K. Andrzejewska J. Zeair S. Sluzar T. Syczewska M. Butkiewicz J. Uminski M. ( 2003) Rapid correction of prothrombin time after low-dose recombinant factor VIIA in patients undergoing orthotopic liver transplantation. Transplantation Proceedings, 35, 2323 2325.
26. Tonda R. Galan A.M. Pino M. Cirera I. Bosch J. Hernandez M.R. Ordinas A. Escolar G. ( 2003) Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model. Journal of Hepatology, 39, 954 959.